CoChat
Sign Up
Cited by 2,293Bariatric Surgery and OutcomesMinimally Invasive Surgical TechniquesDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus

Open access
Pories, Walter J., Swanson, Melvin S., MacDonald, Kenneth G., Long, Stuart B., Morris, Patricia G., Brown, Brenda M., Barakat, Hisham A., deRamon, Richard A., Israel, Gay, Dolezal, Jeanette M., Dohm, Lynis·1995·Annals of Surgery
DOI 10.1097/00000658-199509000-00011PMC PMC1234815
Open this paper in CoChat — free account

Abstract

OBJECTIVE: This report documents that the gastric bypass operation provides long-term control for obesity and diabetes. SUMMARY BACKGROUND DATA: Obesity and diabetes, both notoriously resistant to medical therapy, continue to be two of our most common and serious diseases. METHODS: Over the last 14 years, 608 morbidly obese patients underwent gastric bypass, an operation that restricts caloric intake by (1) reducing the functional stomach to approximately 30 mL, (2) delaying gastric emptying with a c. 0.8 to 1.0 cm gastric outlet, and (3) excluding foregut with a 40 to 60 cm Roux-en-Y gastrojejunostomy. Even though many of the patients were seriously ill, the operation was performed with a perioperative mortality and complication rate of 1.5% and 8.5%, respectively. Seventeen of the 608 patients (< 3%) were lost to follow-up. RESULTS: Gastric bypass provides durable weight control. Weights fell from a preoperative mean of 304.4 lb (range, 198 to 615 lb) to 192.2 lb (range, 104 to 466) by 1 year and were maintained at 205.4 lb (range, 107 to 512 lb) at 5 years, 206.5 lb (130 to 388 lb) at 10 years, and 204.7 lb (158 to 270 lb) at 14 years. The operation provides long-term control of non-insulin-dependent diabetes mellitus (NIDDM). In those patients with adequate follow-up, 121 of 146 patients (82.9%) with NIDDM and 150 of 152 patients (98.7%) with glucose impairment maintained normal levels of plasma glucose, glycosylated hemoglobin, and insulin. These antidiabetic effects appear to be due primarily to a reduction in caloric intake, suggesting that insulin resistance is a secondary protective effect rather than the initial lesion. In addition to the control of weight and NIDDM, gastric bypass also corrected or alleviated a number of other comorbidities of obesity, including hypertension, sleep apnea, cardiopulmonary failure, arthritis, and infertility. Gastric bypass is now established as an effective and safe therapy for morbid obesity and its associated morbidities. No other therapy has produced such durable and complete control of diabetes mellitus.

Overview

Integrity signals

Registry

Crossref · 10.1097/00000658-199509000-00011

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Cited by

Sorted by citations

See all 2,293

Related

See all

Metadata

Authors
Pories, W. J., Swanson, M. S., MacDonald, K. G., Long, S. B., Morris, P. G., Brown, B. M., Barakat, H. A., deRamon, R. A., Israel, G., Dolezal, J. M., & Dohm, L.
Affiliations
East Carolina University (US)
ORCID
Pories, Walter J.
Venue
Annals of Surgery
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
1995-09
Volume
222
Issue
3
Pages
339-352
ISSN
0003-4932 (ISSN-L)
DOI
10.1097/00000658-199509000-00011
PMC
PMC1234815
OpenAlex
W2038034590
Cited by
2,293
References
18
Citations by year
2026: 27 · 2025: 34 · 2024: 37 · 2023: 47 · 2022: 53 · 2021: 56 · 2020: 54 · 2019: 79 · 2018: 70 · 2017: 82 · 2016: 97 · 2015: 119 · 2014: 129 · 2013: 127 · 2012: 139
FWCI
15.09
Type
journal article
Language
en
Open access
Locations
  • Annals of Surgery (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • The Scholarship East Carolina University's Institutional Repository (East Carolina University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
obesity, adult-onset diabetes mellitus, type 2 diabetes, gastric bypass, bariatric surgery, weight loss, diabetes remission, insulin resistance, Roux-en-Y gastrojejunostomy, obesity-related comorbidities, hypertension, sleep apnea, infertility, long-term outcomes, surgical complications, caloric restriction, HbA1c, insulin requirement
MeSH terms
Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Male, Middle Aged, Obesity, Morbid, Gastric Bypass, Weight Loss

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review